Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,195,420 | 2,357,520 | 1,583,950 | 746,980 | 2,568,050 |
| Depreciation Amortization | 0 | 388,550 | 275,990 | 110,950 | 439,860 |
| Other Working Capital | 81,110 | -37,050 | -184,310 | -1,100 | 52,950 |
| Other Operating Activity | 718,270 | 595,650 | 184,690 | 79,970 | 447,900 |
| Operating Cash Flow | $3,994,800 | $3,304,670 | $1,860,320 | $936,800 | $3,508,760 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -561,260 | -345,990 | -226,960 | -100,680 | -589,810 |
| Net Acquisitions | 0 | 0 | 0 | 0 | 205,930 |
| Other Investing Activity | -85,220 | 169,860 | 164,240 | 81,430 | -610,850 |
| Investing Cash Flow | $-646,480 | $-176,130 | $-62,720 | $-19,250 | $-994,730 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -1,065,330 | -1,083,000 | -1,100,100 | -1,045,380 | -784,520 |
| Other Financing Activity | -2,074,960 | -1,547,170 | -631,680 | -236,210 | -1,572,600 |
| Financing Cash Flow | $-3,140,290 | $-2,630,170 | $-1,731,780 | $-1,281,590 | $-2,357,120 |
| Exchange Rate Effect | -2,990 | -5,130 | -6,940 | -12,280 | 8,200 |
| Beginning Cash Position | 2,235,320 | 2,272,400 | 2,308,280 | 2,193,460 | 1,967,360 |
| End Cash Position | 2,440,350 | 2,765,640 | 2,367,140 | 1,817,120 | 2,132,460 |
| Net Cash Flow | $205,020 | $493,240 | $58,860 | $-376,330 | $165,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,994,800 | 3,304,670 | 1,860,320 | 936,800 | 3,508,760 |
| Free Cash Flow | 3,994,800 | 3,304,670 | 1,860,320 | 936,800 | 3,508,760 |